Clinical Trial Update: To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating SHR-1701 in combination with temozolomide for advanced melanoma is in progress, with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• SHR-1701
• Temozolomide (Temozolomide)

Snippet

Sponsor: Yong Chen | Conditions: Melanoma | Phase 2 | Status: UNKNOWN